Child Growth According to Maternal and Child HIV Status in Zimbabwe
Open Access
- 1 September 2017
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 36 (9) , 869-876
Abstract
Background: Growth failure is common among HIV-infected infants, but there are limited data on the effects of HIV exposure or timing of HIV acquisition on growth. Methods: Fourteen thousand one hundred ten infants were enrolled in the Zimbabwe Vitamin A for Mothers and Babies trial in Zimbabwe before the availability of antiretroviral therapy or co-trimoxazole. Anthropometric measurements were taken from birth through 12–24 months of age. Growth outcomes were compared between 5 groups of children: HIV-infected in utero (IU), intrapartum (IP) or postnatally (PN); HIV-exposed uninfected (HEU); and HIV unexposed. Results: Growth failure was common across all groups of children. Compared with HIV-unexposed children, IU-, IP- and PN-infected children had significantly lower length-for-age and weight-for-length Z scores throughout the first 2 years of life. At 12 months, odds ratios for stunting were higher in IU [6.25, 95% confidence interval (CI): 4.20–9.31] and IP infants (4.76, 95% CI: 3.58–6.33) than in PN infants (1.70, 95% CI: 1.16–2.47). Compared with HIV-unexposed infants, HEU infants at 12 months had odds ratios for stunting of 1.23 (95% CI: 1.08–1.39) and wasting of 1.56 (95% CI: 1.22–2.00). Conclusions: HIV-infected infants had very high rates of growth failure during the first 2 years of life, particularly if IU or IP infected, highlighting the importance of early infant diagnosis and antiretroviral therapy. HEU infants had poorer growth than HIV-unexposed infants in the first 12 months of life.Keywords
This publication has 41 references indexed in Scilit:
- Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infantsBMC Pregnancy and Childbirth, 2014
- Maternal HIV infection and other factors associated with growth outcomes of HIV-uninfected infants in Entebbe, UgandaPublic Health Nutrition, 2013
- Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, IndiaBMC Infectious Diseases, 2012
- The Prevalence of Stunting Is High in HIV-1–Exposed Uninfected Infants in KenyaThe Journal of Nutrition, 2012
- Children Who Acquire HIV Infection Perinatally Are at Higher Risk of Early Death than Those Acquiring Infection through Breastmilk: A Meta-AnalysisPLOS ONE, 2012
- Elevations in Mortality Associated with Weaning Persist into the Second Year of Life among Uninfected Children Born to HIV‐Infected MothersClinical Infectious Diseases, 2010
- Role of breastfeeding cessation in mediating the relationship between maternal HIV disease stage and increased child mortality among HIV-exposed uninfected childrenInternational Journal of Epidemiology, 2008
- Time-independent Maternal and Infant Factors and Time-dependent Infant Morbidities including HIV Infection, Contribute to Infant Growth Faltering during the First 2 Years of LifeJournal of Tropical Pediatrics, 2008
- In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapyAIDS, 2006
- A simplified method for diagnosis of gestational age in the newborn infantThe Journal of Pediatrics, 1978